Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 34, 2000 - Issue 4
Submit an article Journal homepage
16
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of Prognostic Factors in Prostate Cancer with Partial Least Squares Analysis

Pernilla Wikström Department of Surgical and Perioperative Sciences, Section for Urology and Andrology, Umeå University Hospital, S-901 85 Umeå, Sweden
,
Per Wikström Department of Surgical and Perioperative Sciences, Section for Urology and Andrology, Umeå University Hospital, S-901 85 Umeå, Sweden
,
Ingela Franck Lissbrant Department of Surgical and Perioperative Sciences, Section for Urology and Andrology, Umeå University Hospital, S-901 85 Umeå, Sweden
,
Anders Bergh Department of Surgical and Perioperative Sciences, Section for Urology and Andrology, Umeå University Hospital, S-901 85 Umeå, Sweden
,
Jan-Erik Damber Department of Surgical and Perioperative Sciences, Section for Urology and Andrology, Umeå University Hospital, S-901 85 Umeå, Sweden
&
Pär Stattin Department of Surgical and Perioperative Sciences, Section for Urology and Andrology, Umeå University Hospital, S-901 85 Umeå, Sweden
Pages 252-256 | Published online: 09 Jul 2009

REFERENCES

  • Fielding LP, Henson DE. Multiple prognostic factors and outcome analysis in patients with cancer. Cancer 1993; 71: 2426–9.
  • Wold S, Johansson E, Cocchi M. PLS-partial least-squares projections to latent structures. In: Kubinyi H, editor. 3D QSAR in drug design, theory, methods, and applications. Leiden: ESCOM Science Publishers; 1993: 523–50.
  • Eriksson L, Hermens JLM, Johansson E, Verhaar HJM, Wold S. Multivariate analysis of aquatic toxicity data with PLS. Aquat Sci 1995; 57(3): 217–41.
  • Stattin P. Damber JE, Karlberg L, Bergh A. Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancer. J Urol 1997; 157: 219–22.
  • Franck Lissbrant I, Stattin P. Damber JE, Bergh A. Vascular density is a predictor of cancer specific survival in prostatic carcinoma. Prostate 1997; 33: 38–45.
  • Franck Lissbrant I, Stattin P. Wikström P. Damber JE, Bergh A. Tumor associated macrophages in human prostate cancer-relation to clinicopathological variables and survival. Int J Oncol, in press.
  • Wikström P. Frank-Lissbrant I, Stattin P. Damber JE, Bergh A. Transforming growth factor beta in prostate cancer. Prostate 1998; 37: 19–29.
  • Stattin P. Bergh A, Karlberg L, Nordgren H, Damber JE. p53 immunoreactivity as prognostic marker for cancer specific survival in prostate cancer. Eur Urol 1996; 30: 65–72.
  • Stattin P. Damber JE, Karlberg L, Nordgren H, Bergh A. Bc1-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia. grade, hormonal status, metastatic growth and survival. Urol Res 1996; 24: 257–64.
  • Stattin P. Bergh A, Karlberg L, Tavelin B, Damber JE. Long-term outcome of conservative therapy in men with voiding symptoms and prostate cancer. Eur Urol 1997; 32: 408–13.
  • Union International Coutre le Cancer (ed.). In: TNM classification of malignant tumours. 2nd ed. Berlin: Springer; 1978; 141–4.
  • Mostofi FK, Sesterhenn IA, Sobin LH. International histological classification of prostate tumours. In: International histological classification of prostate tu-mours. Geneva: World Health Organization, Mostofi FK, (ed.) 1980.
  • Cruciani G, Baroni M, Bonelli D, Clementi S, Ebert C, Skagerberg B. Comparison of chemometric models for QSAR. Quant Struct Act Rel 1990; 9: 101–7.
  • Bone M, Nerstrom B, Overgaard J. The natural history of prostate carcinoma based on a Danish population treated with no intent to cure. Cancer 1997; 80(5): 917–28.
  • Bubendorf L, Sauter G, Moch H, Schmid HP, Gasser TC, Jordan P, et al. Ki-67 labelling index: an indepen-dent predictor of progression in prostate cancer treated by radical prostatectomy. J Pathol 1996; 178(4): 437–41.
  • Bettencourt MC, Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Moul JVV. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. J Urol 1996; 156: 1064–8.
  • Bostwick DG, Wheeler TM, Blute M, Barrett DM, MacLennan GT, Sebo TJ, et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996; 48: 47–57.
  • Rogatsch H, Hittmair A, Reissigl A, Mikuz G, Feichtinger H. Microvessel density in core biopsies of prostatic adenocarcinoma: a stage predictor? J Pathol 1997; 182(2): 205–10.
  • Kim IY, Ahn HJ, Lang S, Oefelein MG, Oyasu R, Kozlowski JM, et al. Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients. Clin Cancer Res 1998; 4(7): 1625–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.